t: 01582 726661
e: secretariat@scs.org.uk
Cosmetic Claims and the Use of AI to Generate and Translate Articles – Opportunities and Threats on a Regulatory Perspective
Time: 4:30 pm - 5:00 pm
Date: 11 November
Theatre: Inform 2
11-11-2025 16:30
11-11-2025 17:00
Europe/London
Cosmetic Claims and the Use of AI to Generate and Translate Articles – Opportunities and Threats on a Regulatory Perspective
While AI saves time generating content, it also poses risks of misleading claims and increased burden on regulatory teams… Learning Points Regulatory Risks of AI-Generated Content AI may use unverified or non-compliant sources (e.g., blogs, competitor content), leading to misleading or unsubstantiated product claims. Importance of Evidence-Based Claims Product claims must be unique, accurate, and… Read more »
SCS FormulateWhile AI saves time generating content, it also poses risks of misleading claims and increased burden on regulatory teams…
Learning Points
- Regulatory Risks of AI-Generated Content
AI may use unverified or non-compliant sources (e.g., blogs, competitor content), leading to misleading or unsubstantiated product claims. - Importance of Evidence-Based Claims
Product claims must be unique, accurate, and supported by robust, scientific evidence—not inferred or copied from external content. - Challenges in AI Translations
AI-generated translations often ignore cultural context and local regulatory requirements, increasing the risk of non-compliance. - Impact on Regulatory Workload
Rather than reducing workload, poorly supervised AI use can create more work for regulatory teams needing to verify and correct content. - Need for a Clear AI Use Framework
Setting internal guidelines (e.g., prompt structure, approval processes) and using local AI tools can help ensure compliance and confidentiality.
Speakers
Dr Sandrine Henry de Hassonville Director - Cambridge Pharma Services Ltd
« Back


